Stopping lopinavir/ritonavir in COVID-19 patients: duration of the drug interacting effect

被引：48
|
作者：
Stader, Felix [1 ,2 ,3 ]
Khoo, Saye [4 ]
Stoeckle, Marcel [1 ,2 ,3 ]
Back, David [4 ]
Hirsch, Hans H. [1 ,2 ,5 ]
Battegay, Manuel [1 ,2 ,3 ]
Marzolini, Catia [1 ,2 ,3 ,4 ]
机构：
[1] Univ Hosp Basel, Div Infect Dis & Hosp Epidemiol, Dept Med, Basel, Switzerland
[2] Univ Hosp Basel, Div Infect Dis & Hosp Epidemiol, Dept Clin Res, Basel, Switzerland
[3] Univ Basel, Basel, Switzerland
[4] Univ Liverpool, Inst Translat Med, Dept Mol & Clin Pharmacol, Liverpool, Merseyside, England
[5] Univ Basel, Dept Biomed, Transplantat & Clin Virol, Basel, Switzerland
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2020年 / 75卷 / 10期
关键词：
ENZYMES; CYP1A2; CYP3A4;
D O I：
10.1093/jac/dkaa253
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
下载
收藏
页码：3084 / 3086
页数：3
相关论文
共 50 条
  • [1] Remdesivir versus ritonavir/lopinavir in COVID-19 patients
    Antonio Vitiello
    Francesco Ferrara
    Irish Journal of Medical Science (1971 -), 2021, 190 : 1249 - 1250
  • [2] Risk of bradycardia with lopinavir/ritonavir in COVID-19 patients
    Reactions Weekly, 2020, 1814 (1) : 9 - 9
  • [3] Remdesivir versus ritonavir/lopinavir in COVID-19 patients
    Vitiello, Antonio
    Ferrara, Francesco
    IRISH JOURNAL OF MEDICAL SCIENCE, 2021, 190 (03) : 1249 - 1250
  • [4] Population pharmacokinetics of lopinavir/ritonavir in Covid-19 patients
    Alvarez, Jean Claude
    Moine, Pierre
    Davido, Benjamin
    Etting, Isabelle
    Annane, Djillali
    Larabi, Islam Amine
    Simon, Nicolas
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (03) : 389 - 397
  • [5] Population pharmacokinetics of lopinavir/ritonavir in Covid-19 patients
    Jean Claude Alvarez
    Pierre Moine
    Benjamin Davido
    Isabelle Etting
    Djillali Annane
    Islam Amine Larabi
    Nicolas Simon
    European Journal of Clinical Pharmacology, 2021, 77 : 389 - 397
  • [6] Lopinavir–ritonavir in severe COVID-19
    Hannah Stower
    Nature Medicine, 2020, 26 : 465 - 465
  • [7] Lopinavir-Ritonavir and Liver Involvement in Patients With COVID-19
    Lv, Xiu-He
    Yang, Jin-Lin
    Deng, Kai
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 (05): : 1099 - 1099
  • [8] Plasma Concentrations and Safety of Lopinavir/Ritonavir in COVID-19 Patients
    Chouchana, Laurent
    Boujaafar, Sana
    Gana, Ines
    Preta, Laure-Helene
    Regard, Lucile
    Legendre, Paul
    Azoulay, Celia
    Canoui, Etienne
    Zerbit, Jeremie
    Carlier, Nicolas
    Terrier, Benjamin
    Kerneis, Solen
    Batista, Rui
    Treluyer, Jean-Marc
    Zheng, Yi
    Benaboud, Sihem
    THERAPEUTIC DRUG MONITORING, 2021, 43 (01) : 131 - 135
  • [9] Lopinavir/ritonavir delays COVID-19 recovery in paediatric patients
    Reactions Weekly, 2022, 1903 (1) : 8 - 8
  • [10] A Trial of Lopinavir-Ritonavir in Covid-19
    Carmona-Bayonas, Alberto
    Jimenez-Fonseca, Paula
    Castanon, Eduardo
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (21):
12345